I am a PhD candidate (Dept. of Biology, University of Patras, Greece) currently investigating drug resistance mechanisms and signaling pathways in hematological disorders and solid tumors. My studies are focused on proteasome inhibitors and the role of key kinases and transcription factors in the emergence of resistance.
Subham Preetam is the founder & chief executive officer of India-based startup company N BASE (Nano-Bio Advanced Sustainable Engineering). He is a passionate researcher in the fields of nanotechnology, biomedical engineering, and biorobotics research. He is dedicated to the advancement of precision medicine and successful preclinical research to enhance the quality of life for individuals.